Paris, France and Camberley, UK – 26 May 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 25 May 2020, the following Director purchased ordinary shares of €1/15 each in the Company (the “Ordinary Shares”):
https://novacyt.com/wp-content/uploads/2020/05/Novacyt-Directors-Dealings-ENGLISH-26.05.2020.pdf
